{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:32:39Z","timestamp":1790775159311,"version":"4.1.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T00:00:00Z","timestamp":1371600000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0066637","type":"journal-article","created":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T21:07:05Z","timestamp":1371676025000},"page":"e66637","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity"],"prefix":"10.1371","volume":"8","author":[{"given":"Maria","family":"Hoeltzenbein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Stieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelin","family":"Wacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,6,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/heartjnl-2012-302249","article-title":"Allopurinol: novel indications in cardiovascular disease","volume":"98","author":"A Struthers","year":"2012","journal-title":"Heart"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000336378","article-title":"Antioxidant therapies: a potential role in perinatal medicine","volume":"96","author":"SL Miller","year":"2012","journal-title":"Neuroendocrinology"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Hoentjen F, Seinen ML, Hanauer SB, de Boer NK, Rubin DT, <etal>et al<\/etal>.. (2012) Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis. 10.1002\/ibd.23021 [doi].","DOI":"10.1002\/ibd.23021"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/15257770.2011.597371","article-title":"Allopurinol enhances the activity of hypoxanthine-guanine phosphoribosyltransferase in inflammatory bowel disease patients during low-dose thiopurine therapy: preliminary data of an ongoing series","volume":"30","author":"ML Seinen","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Seinen ML, de Boer NK, van Hoorn ME, van Bodegraven AA, Bouma G (2012) Safe use of allopurinol and low-dose mercaptopurine therapy during pregnancy in an ulcerative colitis patient. Inflamm Bowel Dis. 10.1002\/ibd.22945 [doi].","DOI":"10.1002\/ibd.22945"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/ajmg.a.34139","article-title":"Potential teratogenic effects of allopurinol: a case report","volume":"155A","author":"M Kozenko","year":"2011","journal-title":"Am J Med Genet A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.reprotox.2008.05.064","article-title":"Using observational cohort data for studying drug effects on pregnancy outcome\u2013methodological considerations","volume":"26","author":"C Schaefer","year":"2008","journal-title":"Reprod Toxicol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ajmg.a.20249","article-title":"Phenotypic abnormalities: terminology and classification","volume":"123A","author":"JH Merks","year":"2003","journal-title":"Am J Med Genet A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/bdra.10012","article-title":"Guidelines for case classification for the National Birth Defects Prevention Study","volume":"67","author":"SA Rasmussen","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-0029-1241833","article-title":"Kurzmitteilung zu den Perzentilenwerten f\u00fcr die K\u00f6rperma\u00dfe der Neugeborenen","volume":"214","author":"M Voigt","year":"2010","journal-title":"Z Geburtshilfe Neonatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.reprotox.2008.06.006","article-title":"Statistical methods for estimating the probability of spontaneous abortion in observational studies\u2013analyzing pregnancies exposed to coumarin derivatives","volume":"26","author":"R Meister","year":"2008","journal-title":"Reprod Toxicol"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Coddington CC, Albrecht RC, Cefalo RC (1979) Gouty nephropathy and pregnancy. Am J Obstet Gynecol 133: 107\u2013108. 0002-9378(79)90420-4 [pii].","DOI":"10.1016\/0002-9378(79)90420-4"},{"key":"ref13","first-page":"S39","article-title":"Chemotherapy in treatment of non-hodgkin&apos;s lymphoma in pregnancy (Abstract)","volume":"97","author":"ML Brown","year":"2001","journal-title":"Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1471-0528.1997.tb11979.x","article-title":"Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial","volume":"104","author":"AM Gulmezoglu","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"ref15","first-page":"226","article-title":"Pregnancy and von Gierke&apos;s disease","volume":"47","author":"M Farber","year":"1976","journal-title":"Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.leukres.2008.05.019","article-title":"Pregnancy in chronic lymphocytic leukemia: experience with fetal exposure to chlorambucil","volume":"33","author":"R Ali","year":"2009","journal-title":"Leuk Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1254\/jjp.22.201","article-title":"Comparison of teratogenic action of substances related to purine metabolism in mouse embryos","volume":"22","author":"T Fujii","year":"1972","journal-title":"Jpn J Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3181\/00379727-116-29345","article-title":"Teratogenesis: Effects of substituted purines and the influence of the 4 hydroxypyrazolonpyrimidine in the rat","volume":"116","author":"JR Bragonier","year":"1964","journal-title":"Proc Soc Exp Biol Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ajmg.a.35223","article-title":"Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services","volume":"158A","author":"M Hoeltzenbein","year":"2012","journal-title":"Am J Med Genet A"},{"key":"ref20","unstructured":"Briggs GG, Freeman RK, and Yaffe SJ (2011) Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Lippincott Williams&amp;Wilkins."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/bdra.22865","article-title":"Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects","volume":"94","author":"M Anderka","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajog.2012.04.035","article-title":"Maternal BMI, glucose tolerance, and adverse pregnancy outcomes","volume":"207","author":"AM Stuebe","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/art.27338","article-title":"Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort","volume":"62","author":"V Bhole","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00467-001-0776-z","article-title":"In utero exposure to immunosuppressive drugs: experimental and clinical studies","volume":"17","author":"A Tendron","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"A Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref26","volume":"43","unstructured":"Norby SM, Milliner DS (2004) Outcomes and complications of pregnancy in women with primary hyperoxaluria. Am J Kidney Dis <volume>43<\/volume>: : 277\u2013285. S0272638603014896 [pii]."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/archpedi.161.8.745","article-title":"Prepregnancy obesity as a risk factor for structural birth defects","volume":"161","author":"DK Waller","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/bdra.20679","article-title":"Prepregnancy obesity: a complex risk factor for selected birth defects","volume":"88","author":"SL Carmichael","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/bdra.20533","article-title":"Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines","volume":"85","author":"JC Carey","year":"2009","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ajmg.c.30311","article-title":"The importance of dysmorphology in the identification of new human teratogens","volume":"157","author":"KL Jones","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0066637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T22:23:19Z","timestamp":1563229399000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0066637"}},"subtitle":[],"editor":[{"given":"Ramani","family":"Ramchandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,19]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0066637","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,19]]}}}